Qianrou Zhang – Trademark Portfolio

Entity Type: 01

Qianrou Zhang holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 6 (Metal Goods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SYNVIXELIS and KYNXELVIRIX. The owner is based in Zhongshan City, Guangdong Province.

No. 2, Lane 2, South Heng Street, Zhangjiawei,

Xianlong, Guzhen Town

Zhongshan City, Guangdong Province 528400 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Qianrou Zhang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Qianrou Zhang have?

Qianrou Zhang has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Qianrou Zhang file in?

Qianrou Zhang files trademarks across 2 Nice Classification classes. The most active classes are Class 6 (Metal Goods), Class 5 (Pharmaceuticals). Class 6 covers common metals and their alloys; metal building materials; transportable buildings of metal.

What are Qianrou Zhang's most well-known trademarks?

Qianrou Zhang's registered trademark portfolio includes well-known marks such as SYNVIXELIS and KYNXELVIRIX. These are among 2 currently registered trademarks in the portfolio.

What is Qianrou Zhang's trademark registration success rate?

Qianrou Zhang has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.